NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...

NEW YORK, Jan 31 (Reuters) - Mylan Laboratories Inc. said on Wednesday it was reorganizing its executive ranks after acquiring a controlling interest in India's Matrix Laboratories Ltd. , and that ...

TEL AVIV (MarketWatch) -- Mylan Laboratories Inc., the Pittsburgh pharmaceutical producer, said it definitively agreed to pay 4.9 billion euros, or about $6.7 billion, for the generic-drug operations ...

PITTSBURGH (AP) -- One of the world's largest generic drug makers, Mylan Laboratories Inc., will buy King Pharmaceuticals Inc. for $4 billion in stock as Mylan makes a stronger foray into the branded ...

Mylan Pharmaceuticals Inc. recently filed an IPR petition, PTAB-IPR2023-00099, seeking cancellation of claims 1-3 of U.S. Patent No. 10,857,205, assigned to Regeneron Pharmaceuticals, Inc. According ...

The Federal Circuit reversed a Patent Trial and Appeal Board (“Board”) decision finding the challenged claims of Sanofi-Aventis’ ’614 patent unpatentable as obvious. Background Mylan petitioned for ...

Billionaire investor Carl Icahn has dropped his $5.39 billion offer to buy Mylan Laboratories Inc. and tendered his shares after regulators opened an investigation of a Mylan pain patch that was ...

NEW YORK (CBS.MW) - Mylan Labs reported fiscal first-quarter earnings of $82 million, or 30 cents a share, in line with year-earlier per share results. Excluding gains on legal settlements, earnings ...

How Parents Harnessed the Power of Social Media to Challenge EpiPen Prices A few vocal parents harnessed the power of Facebook and Twitter to pressure pharmaceutical firm Mylan to lower its price on ...

Shares of Mylan Laboratories Inc. gained 10% after billionaire financier Carl Icahn received clearance from the Federal Trade Commission to acquire as much as 12% of the largest U.S. maker of generic ...

The proposed settlement, which requires a judge’s approval, would resolve a legal battle that began after the company, in 2016, raised the price for two EpiPens to $608 from $100. By Jesus Jiménez The ...